Stock listing
Lang & Schwarz:A2AFL6 Syndax Pharmaceuticals, Inc. Aktie
German listing (Lang & Schwarz) of Syndax Pharmaceuticals, Inc. · home listing NASDAQ:SNDX
Follow Syndax Pharmaceuticals, Inc. into a list and get an email when it puts out news.
Home listing price · NASDAQ:SNDX
$13.09 USD +0.19 (+1.5%)
Close on Oct 19, 2026 · This listing has no price on 6ix; the price shown is the home listing's, NASDAQ:SNDX
- Day range
- $12.80 – $13.18 USDOct 19, 2026
- Volume
- 2.19M sharesOct 19, 2026
- Market cap
- $1.17B USDAt the close on Oct 19, 2026 · price × 89.30M shares outstanding
Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| NASDAQ:SNDX · Home | $13.09 USD | +0.19 (+1.5%) | 2,192,489 | $12.90 | $13.18 | $12.80 | $12.90 | Close on Oct 19, 2026 |
| Frankfurt:1T3 | €11.53 EUR | -0.565 (-4.7%) | — | €11.53 | €11.53 | €11.53 | €12.09 | Close on Oct 19, 2026 |
Daily closes
Last 3 months, Jul 20, 2026 – Oct 19, 2026 · NASDAQ:SNDX · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $13.09 | +0.19 | +1.5% | $12.90 | $13.18 | $12.80 | 2,192,489 | |
| $12.90 | -0.75 | -5.5% | $13.65 | $13.65 | $12.82 | 2,837,693 | |
| $13.65 | +0.12 | +0.9% | $13.58 | $14.05 | $13.43 | 2,625,676 | |
| $13.53 | -0.42 | -3.0% | $13.92 | $14.01 | $13.39 | 3,038,091 | |
| $13.95 | -2.60 | -15.7% | $14.61 | $14.74 | $13.49 | 6,801,117 | |
| $16.55 | -0.44 | -2.6% | $16.88 | $16.95 | $16.37 | 2,030,015 | |
| $16.99 | +0.09 | +0.5% | $16.91 | $17.42 | $16.78 | 1,459,153 | |
| $16.90 | -0.13 | -0.8% | $16.90 | $17.29 | $16.39 | 2,142,493 | |
| $17.03 | -0.34 | -2.0% | $17.17 | $17.70 | $17.03 | 1,588,600 | |
| $17.37 | -0.46 | -2.6% | $17.99 | $18.19 | $16.85 | 1,135,100 | |
| $17.83 | +0.23 | +1.3% | $17.58 | $17.98 | $17.57 | 1,459,800 | |
| $17.60 | -0.62 | -3.4% | $18.46 | $18.46 | $17.52 | 2,558,000 | |
| $18.22 | -0.58 | -3.1% | $18.56 | $18.87 | $18.05 | 1,431,500 | |
| $18.80 | +0.565 | +3.1% | $18.28 | $18.94 | $17.95 | 1,729,300 | |
| $18.24 | +0.375 | +2.1% | $17.90 | $18.31 | $17.75 | 1,499,000 | |
| $17.86 | -0.34 | -1.9% | $18.16 | $18.16 | $17.60 | 1,554,100 | |
| $18.20 | +0.23 | +1.3% | $18.03 | $18.35 | $17.77 | 1,343,100 | |
| $17.97 | +0.33 | +1.9% | $17.52 | $18.11 | $17.18 | 2,068,500 | |
| $17.64 | -0.545 | -3.0% | $18.20 | $18.47 | $17.09 | 2,086,700 | |
| $18.19 | +0.115 | +0.6% | $18.23 | $18.56 | $17.97 | 1,674,500 | |
| $18.07 | +0.45 | +2.6% | $17.74 | $18.45 | $17.39 | 2,108,300 | |
| $17.62 | -0.06 | -0.3% | $17.65 | $17.95 | $17.37 | 5,181,000 | |
| $17.68 | +0.40 | +2.3% | $17.53 | $18.05 | $17.37 | 2,582,100 | |
| $17.28 | -0.81 | -4.5% | $18.08 | $18.11 | $17.25 | 2,332,300 | |
| $18.09 | -0.26 | -1.4% | $18.19 | $18.19 | $17.71 | 1,128,000 | |
| $18.35 | +0.17 | +0.9% | $18.30 | $18.68 | $18.24 | 1,186,800 | |
| $18.18 | -0.64 | -3.4% | $19.01 | $19.02 | $18.02 | 1,223,100 | |
| $18.82 | -1.02 | -5.1% | $19.67 | $19.69 | $18.40 | 1,651,600 | |
| $19.84 | -0.10 | -0.5% | $19.82 | $20.21 | $19.69 | 1,236,900 | |
| $19.94 | -0.62 | -3.0% | $20.19 | $20.48 | $19.90 | 1,204,900 | |
| $20.56 | -0.12 | -0.6% | $20.46 | $21.00 | $20.46 | 1,359,700 | |
| $20.68 | -0.10 | -0.5% | $20.85 | $20.99 | $20.54 | 1,920,700 | |
| $20.78 | +0.68 | +3.4% | $20.23 | $21.00 | $19.97 | 2,016,000 | |
| $20.10 | +0.81 | +4.2% | $19.29 | $20.15 | $19.09 | 1,405,800 | |
| $19.29 | -0.25 | -1.3% | $19.44 | $19.46 | $19.00 | 1,396,500 | |
| $19.54 | -0.62 | -3.1% | $19.98 | $20.05 | $19.47 | 1,042,300 | |
| $20.16 | +0.07 | +0.3% | $20.01 | $20.23 | $19.70 | 652,400 | |
| $20.09 | +0.17 | +0.9% | $19.92 | $20.22 | $19.60 | 789,700 | |
| $19.92 | +0.35 | +1.8% | $19.73 | $20.40 | $19.70 | 975,002 | |
| $19.57 | -0.08 | -0.4% | $19.70 | $19.87 | $19.17 | 1,443,931 | |
| $19.65 | -0.10 | -0.5% | $19.93 | $20.28 | $19.25 | 1,695,900 | |
| $19.75 | -1.02 | -4.9% | $20.39 | $20.72 | $19.64 | 1,122,000 | |
| $20.77 | +0.855 | +4.3% | $20.67 | $20.88 | $20.01 | 1,186,600 | |
| $19.92 | +0.155 | +0.8% | $19.83 | $20.10 | $19.67 | 1,014,900 | |
| $19.76 | -0.08 | -0.4% | $19.52 | $20.28 | $19.29 | 1,096,400 | |
| $19.84 | +0.76 | +4.0% | $19.08 | $19.86 | $18.82 | 1,251,100 | |
| $19.08 | -0.72 | -3.6% | $19.89 | $20.02 | $19.04 | 1,195,100 | |
| $19.80 | -0.49 | -2.4% | $20.26 | $20.71 | $19.69 | 1,069,400 | |
| $20.29 | -0.08 | -0.4% | $20.46 | $20.58 | $19.93 | 790,971 | |
| $20.37 | -0.03 | -0.1% | $20.40 | $20.65 | $20.07 | 1,016,688 | |
| $20.40 | +0.64 | +3.2% | $19.96 | $20.41 | $19.72 | 1,247,600 | |
| $19.76 | -0.16 | -0.8% | $19.61 | $20.39 | $19.38 | 1,476,600 | |
| $19.92 | +0.84 | +4.4% | $17.31 | $20.31 | $17.20 | 3,775,000 | |
| $19.08 | -0.16 | -0.8% | $19.56 | $19.85 | $19.00 | 2,043,900 | |
| $19.24 | +0.19 | +1.0% | $19.01 | $19.41 | $18.68 | 1,611,100 | |
| $19.05 | -0.43 | -2.2% | $19.37 | $19.50 | $18.64 | 1,206,200 | |
| $19.48 | +0.26 | +1.4% | $19.17 | $19.66 | $18.83 | 1,102,600 | |
| $19.22 | -0.41 | -2.1% | $19.74 | $19.89 | $18.85 | 1,747,100 | |
| $19.63 | -0.89 | -4.3% | $20.48 | $20.48 | $19.40 | 939,100 | |
| $20.52 | -0.29 | -1.4% | $21.09 | $21.57 | $20.50 | 1,098,200 | |
| $20.81 | -0.40 | -1.9% | $21.38 | $21.44 | $20.57 | 1,229,000 | |
| $21.21 | -0.84 | -3.8% | $21.80 | $21.88 | $21.17 | 1,306,500 | |
| $22.05 | -0.59 | -2.6% | $22.44 | $22.75 | $21.83 | 1,059,700 | |
| $22.64 | +0.35 | +1.6% | $22.37 | $22.72 | $22.10 | 1,185,391 | |
| $22.29 | -0.51 | -2.2% | $22.95 | $23.28 | $22.28 | 1,309,278 |
- Ticker
- Lang & Schwarz:A2AFL6
- Asset type
- Stock
- Sector
- Health care
- Industry
- Biotechnology
- Exchange
- Lang & Schwarz
- Currency
- EUR
What changed lately
Latest news release · Oct 15, 2026
Syndax’s Revuforj® (revumenib) Named to TIME’s Best Inventions of 2026 List
Latest earnings call · Aug 4, 2026
Syndax Pharmaceuticals (NASDAQ:SNDX) Q2 2026 Earnings Call
Replay and transcript
Latest deck · Aug 4, 2026
Q2 2026 Earnings Presentation
Earnings · 16 slides
Calls
Replays
Syndax Pharmaceuticals (NASDAQ:SNDX) Q2 2026 Earnings Call
Tue, Aug 04, 2026 · 4:30 PM ET
Watch TranscriptSyndax Pharmaceuticals (NASDAQ:SNDX) Q1 2026 Earnings Call
Thu, Apr 30, 2026 · 4:30 PM ET
Watch TranscriptSyndax Pharmaceuticals (NASDAQ:SNDX) Q4 2025 Earnings Call
Thu, Feb 26, 2026 · 7:30 PM ET
Watch Transcript
Latest news
Syndax’s Revuforj® (revumenib) Named to TIME’s Best Inventions of 2026 List
Oct 15, 2026
Closed $12.90 (-5.5%) on Oct 16, 2026
Syndax Announces Topline Results from MAXPIRe Phase 2 Trial of Axatilimab in Idiopathic Pulmonary Fibrosis
Oct 12, 2026
Closed $13.95 (-15.7%) on Oct 13, 2026
Syndax Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
Oct 2, 2026
Closed $17.83 (+1.3%) on Oct 5, 2026
Syndax Reports Second Quarter 2026 Financial Results and Provides Business Update
Aug 4, 2026
Closed $19.92 (+4.4%) on Aug 5, 2026
Syndax to Announce Second Quarter 2026 Financial Results and Host Conference Call and Webcast on August 4, 2026
Jul 28, 2026
Closed $19.63 (-4.3%) on Jul 28, 2026
Syndax to Highlight Late-Stage Programs and Unveil New Pipeline Assets at R&D Event
Jul 14, 2026
Closed $24.13 (+5.4%) on Jul 14, 2026
Decks
Q2 2026 Earnings Presentation
Earnings · 16 slides · Aug 4, 2026
Investor Presentation (August 2026)
Investor deck · 43 slides · August 2026
Investor Day (July 2026)
Investor day · 81 slides · Jul 14, 2026
Q1 2026 Earnings Presentation
Earnings · 18 slides · Apr 30, 2026
Syndax Pharmaceuticals, Inc. on 6ix
- Sector
- Health care
- Industry
- Biotechnology
- News releases
- 34 in the last 12 months · 197 in all · newest Oct 15, 2026 · oldest 2019
- Calls
- 22 calls with a replay · 22 with a transcript · latest Aug 4, 2026
- Decks
- 40 decks · latest Aug 4, 2026
Where Syndax Pharmaceuticals, Inc. is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NASDAQ:SNDX · Home listing | NASDAQ | United States | USD |
| gettex:1T3 | gettex | Germany | EUR |
| Tradegate:1T3 | Tradegate | Germany | EUR |
| BOATS:SNDX | BOATS | United States | USD |
| LS Exchange:A2AFL6 | LS Exchange | Germany | EUR |
| Lang & Schwarz:A2AFL6 · This page | Lang & Schwarz | Germany | EUR |
| Dusseldorf:1T3 | Dusseldorf | Germany | EUR |
| Frankfurt:1T3 | Frankfurt | Germany | EUR |
| Munich:1T3 | Munich | Germany | EUR |
| Stuttgart:1T3 | Stuttgart | Germany | EUR |
Log in to ask 6ix AI your own questions about Syndax Pharmaceuticals, Inc.